首页> 外文期刊>International Journal of Legal Medicine >Comparison of urine results concerning co-consumption of illicit heroin and other drugs in heroin and methadone maintenance programs
【24h】

Comparison of urine results concerning co-consumption of illicit heroin and other drugs in heroin and methadone maintenance programs

机译:比较海洛因和美沙酮维持计划中共同服用非法海洛因和其他药物的尿液结果

获取原文
获取原文并翻译 | 示例
           

摘要

Urine samples of patients from a heroin maintenance program (HMP) and a methadone maintenance program (MMP) were chromatographically analyzed 1 month before and 6 and 12 months into treatment for the presence of classical markers of heroin use as well as for the presence of markers for illicit heroin abuse. Furthermore, the samples were immunochemically tested for cannabinoids, cocaine metabolites, amphetamine, methylendioxyamphetamines and benzodiazepines. A co-consumption of illicit heroin (HER) in the HMP was determined to be 50% but was significantly lower compared to the MMP with a co-use of 71%. The incidence was high because not only acetylcodeine (AC) as a very specific marker was considered but also other marker substances for illicit HER use. Amphetamines played only a minor part in both collectives, and the proportion of HER and methadone patients using cocaine was similar and decreased during treatment. Also, the benzodiazepine use decreased, and cannabis use was high in both collectives during treatment. Considering only the AC in the present study, a co-use of illicit HER in the HMP was similar to previous reports concerning HER-assisted treatment programs. If additional marker substances were examined, the suspicion of a co-use of illicit HER is markedly enhanced.
机译:对来自海洛因维持计划(HMP)和美沙酮维持计划(MMP)的患者的尿液样品进行色谱分析,分别在治疗前1个月,治疗6个月和12个月时进行了海洛因使用经典标记物和标记物治疗的分析滥用海洛因。此外,还对样品中的大麻素,可卡因代谢产物,苯丙胺,甲基苯二甲氧基苯丙胺和苯并二氮杂进行了免疫化学测试。确定HMP中非法海洛因(HER)的共同消费量为50%,但与MMP相比,显着更低,共消费71%。发生率很高,因为不仅考虑了乙酰可待因(AC)作为非常特殊的标记,而且考虑了其他用于非法HER的标记物质。苯丙胺在这两个群体中只占很小的比例,使用可卡因的HER和美沙酮患者的比例相似,并且在治疗期间有所下降。此外,在治疗期间,两个集体的苯二氮卓类药物的使用量均减少,大麻使用量较高。在本研究中仅考虑AC,HMP中非法HER的共同使用与先前有关HER辅助治疗计划的报道相似。如果检查了其他标记物,则明显增加了对非法HER并用的怀疑。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号